Myositis following treatment with high dose interleukin-2 for malignancy.
Finger
D R
DR
Plotz
P H
PH
Heywood
G
G
D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D008875:Middle Aged; D009220:Myositis / Q000139:chemically induced*
D007376:Interleukin-2